Related Experiment Video

Updated: Aug 30, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma

Claudio Talora1, Antonio F Campese, Diana Bellavia

  • 1Laboratory of Molecular Pathology, Department of Experimental Medicine and Pathology, University La Sapienza, Viale Regina Elena 324, 00161 Rome, Italy.

EMBO Reports
|October 21, 2003
PubMed

Insights

Notch3 signaling inhibits E2A activity by upregulating pre-TCR, promoting T-cell lymphoma development. This study reveals a novel interaction between Notch and E2A pathways in neoplastic transformation.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Immunology

Background:

  • The Notch and E2A pathways play critical roles in cell fate determination and cancer development.
  • Notch signaling generally promotes tumorigenesis, while E2A suppresses it.
  • The interplay between Notch and E2A in regulating neoplastic transformation is not fully understood.

Purpose of the Study:

  • To investigate the functional interaction between Notch3 and E2A pathways in T-cell lymphoma.
  • To elucidate the mechanism by which Notch3 signaling influences E2A activity and neoplastic transformation.

Main Methods:

  • Utilized Notch3 transgenic mice models.
  • Analyzed thymocytes and T lymphoma cells.
  • Assessed transcriptional activation, DNA binding activity, and protein/mRNA levels of E2A.
  • Investigated the role of pTalpha/pre-T-cell antigen receptor (pre-TCR) and extracellular-signalling-regulated kinase 1/2 (ERK1/2) signaling.

Main Results:

  • Notch3 signaling upregulates pTalpha/pre-TCR, leading to decreased E2A DNA binding and transcriptional activity.
  • E2A mRNA and protein levels were unchanged, but its inhibitor, Id1, expression was increased in Notch3-driven T lymphoma.
  • Increased Id1 expression was mediated by pre-TCR-induced ERK1/2 signaling.

Conclusions:

  • Upregulation of pre-TCR signaling is a prerequisite for Notch3-induced E2A inhibition.
  • This Notch3-E2A antagonistic interaction, mediated by pre-TCR and Id1, contributes to T-cell lymphoma development in Notch3 transgenic mice.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...